Jason D Goldman

InstitutionUniversity of Washington
AddressSeattle
Washington
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 2 publications in June 2021 and December 2021
    All Publications
    Bar chart showing 25 publications over 10 distinct years, with a maximum of 10 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dai CL, Kornilov SA, Roper RT, Cohen-Cline H, Jade K, Smith B, Heath JR, Diaz G, Goldman JD, Magis AT, Hadlock JJ. Characteristics and Factors Associated With Coronavirus Disease 2019 Infection, Hospitalization, and Mortality Across Race and Ethnicity. Clin Infect Dis. 2021 12 16; 73(12):2193-2204. PMID: 33608710.
      Citations: 12     Fields:    Translation:Humans
    2. Kates OS, Haydel BM, Florman SS, Rana MM, Chaudhry ZS, Ramesh MS, Safa K, Kotton CN, Blumberg EA, Besharatian BD, Tanna SD, Ison MG, Malinis M, Azar MM, Rakita RM, Morilla JA, Majeed A, Sait AS, Spaggiari M, Hemmige V, Mehta SA, Neumann H, Badami A, Goldman JD, Lala A, Hemmersbach-Miller M, McCort ME, Bajrovic V, Ortiz-Bautista C, Friedman-Moraco R, Sehgal S, Lease ED, Fisher CE, Limaye AP. Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study. Clin Infect Dis. 2021 12 06; 73(11):e4090-e4099. PMID: 32766815.
      Citations: 61     Fields:    Translation:Humans
    3. Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med. 2021 12; 9(12):1407-1418. PMID: 34480861.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    4. Citations: 1     Fields:    
    5. Citations: 3     Fields:    Translation:Humans
    6. Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer. 2021 06; 9(6). PMID: 34117116.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    7. Goldman JD. Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic. Clin Infect Dis. 2021 06 01; 72(11):e844-e847. PMID: 33159196.
      Citations:    Fields:    Translation:HumansPHPublic Health
    8. Goldman JD, Ascierto PA. Perspectives on COVID-19 and cancer immunotherapy: a review series. J Immunother Cancer. 2021 03; 9(3). PMID: 33688023.
      Citations: 1     Fields:    Translation:Humans
    9. Dale CR, Starcher RW, Chang SC, Robicsek A, Parsons G, Goldman JD, Vovan A, Hotchkin D, Gluckman TJ. Surge effects and survival to hospital discharge in critical care patients with COVID-19 during the early pandemic: a cohort study. Crit Care. 2021 02 17; 25(1):70. PMID: 33596975.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    10. Goldman JD, Diaz G, Urba WJ. Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 Jan; 57(1):106174. PMID: 33408020.
      Citations: 1     Fields:    Translation:Humans
    11. Citations: 1     Fields:    Translation:HumansPHPublic Health
    12. Goldman JD, Osinusi A, Marty FM. Racial Disproportionality in Covid Clinical Trials. N Engl J Med. 2020 12 17; 383(25):2486-2487. PMID: 33156580.
      Citations: 9     Fields:    Translation:Humans
    13. Citations: 85     Fields:    Translation:HumansCTClinical Trials
    14. Hegerova L, Gooley TA, Sweerus KA, Maree C, Bailey N, Bailey M, Dunleavy V, Patel K, Alcorn K, Haley R, Johnsen JM, Konkle BA, Lahti AC, Alexander ML, Goldman JD, Lipke A, Lim SJ, Sullivan MD, Pauk JS, Pagel JM. Use of convalescent plasma in hospitalized patients with COVID-19: case series. Blood. 2020 08 06; 136(6):759-762. PMID: 32559767.
      Citations: 59     Fields:    Translation:HumansCellsPHPublic Health
    15. Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020 11 05; 383(19):1827-1837. PMID: 32459919.
      Citations: 368     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    16. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O'Mahony S, Mikacenic C. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020 05 21; 382(21):2012-2022. PMID: 32227758.
      Citations: 983     Fields:    Translation:HumansCellsPHPublic Health
    Goldman's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (89)
    Explore
    _
    Co-Authors (255)
    Explore
    _
    Similar People (60)
    Explore
    _